{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} Use of Bone Morphogenetic Protein in the Lumbar Spine
Activity Steps
Description
Method of Participation in the Learning Process/Evaluation MethodSuccessful completion of this activity includes reading the entire article and successfully completing the post-quiz and an evaluation form.Getting the Most out of the ActivityAs you prepare to participate in this activity, please reflect on your practice and your patients and identify clinical challenges you hope to have addressed.While participating in the training, identify ways you can use newly acquired knowledge, strategies, and skills to enhance patient outcomes and your own professional development.Learning Objectives
After completing this continuing education activity you will be able to:
- Identify the fundamentals of the basic science of bone morphogenetic protein.
- Evaluate the evidence supporting or refuting the use of recombinant bone morphogenetic protein-2 (rhBMP-2) in the lumbar spine.
- Assess the possible adverse effects that may arise from use of rhBMP-2 in the lumbar spine.
Disclosures
Dr. Kern Singh (Editor) has disclosed that he is a consultant advisor to Depuy, Zimmer, and Stryker; is a recipient of royalties from Zimmer, Stryker, Pioneer, Slack Publishing, Thieme, Jaypee Publishing and Lippincott Williams & Wilkins; is a stockholder in Avaz Surgical, LLC and Vital 5, LLC; and his spouse/life partner (if any) have no financial relationships with or financial interests in, any commercial companies pertaining to this educational activity. Dr. Wellington Hsu (author) has disclosed that he was a recipient of grant/research funding from Medtronic Sofamor, and Baxter, Inc.; is a recipient of grant/research funding from Pioneer Surgical; is a consultant/advisor for Stryker, Zimmer, Medtronic, Pioneer Surgical, and Graftys; and his spouse/life partner (if any) have no financial relationships with or financial interests in, any commercial companies pertaining to this educational activity. The remaining faculty and staff in a position to control the content of this CME activity and their spouses/life partners (if any) have disclosed that they have no financial relationships with, or financial interests in, any commercial organizations related to this CME activity.
Credits:
- ACCME 1.5 CME